Chemokine (C-X-C motif) receptor 4 (CXCR4); chemokine (C-X-C motif) ligand 12 (stromal cell–derived factor 1) (CXCL12; SDF-1α) BriefCommunication Pages: 992 - 992
B cell CLL/lymphoma 2 (BCL2; BCL-2); BCL2-like 11 (BCL2L11; BIM); mitogen-activated protein kinase kinase kinase 1 (MAP3K1; MEK) BriefCommunication Pages: 993 - 993
B cell CLL/lymphoma 2 (BCL2; BCL-2); DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58; RIG-I) BriefCommunication Pages: 994 - 994
Phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A) BriefCommunication Pages: 999 - 999
Protein kinase, cAMP-dependent, catalytic, α (PRKACA; PKACA); protein kinase, X-linked (PRKX); patatin-like phospholipase domain containing 6 (PNPLA6; NTE) BriefCommunication Pages: 1003 - 1003
In vitro assay to predict responses to acute lymphoblastic leukemia (ALL) treatment BriefCommunication Pages: 1005 - 1005
Arg-Gly-Asp-Lys (RGDK) lipopeptide for cancer gene delivery to tumor vasculature BriefCommunication Pages: 1007 - 1007
Fusion protein for drug delivery across the blood-brain barrier (BBB) BriefCommunication Pages: 1008 - 1008
MRI-based computational model to differentiate between malignant and benign breast tumors BriefCommunication Pages: 1011 - 1011